scholarly article | Q13442814 |
P50 | author | Stephen B. Baylin | Q28113000 |
Wenbing Xie | Q41634154 | ||
P2093 | author name string | Michael M Seidman | |
Feyruz V Rassool | |||
Li-Rong Yu | |||
Daiming Fan | |||
Yi Cai | |||
Huili Li | |||
Kaichun Wu | |||
Yongzhan Nie | |||
Cynthia A Zahnow | |||
Limin Xia | |||
Wenjie Huang | |||
Ray-Whay Chiu Yen | |||
Yang W Zhang | |||
Wenbing Xie | |||
Marina Bellani | |||
P2860 | cites work | Double strand breaks can initiate gene silencing and SIRT1-dependent onset of DNA methylation in an exogenous promoter CpG island | Q21092482 |
Chromatin deacetylation by an ATP-dependent nucleosome remodelling complex | Q22004265 | ||
Regulation of DNA-damage responses and cell-cycle progression by the chromatin remodelling factor CHD4 | Q24294656 | ||
Oxidative damage targets complexes containing DNA methyltransferases, SIRT1, and polycomb members to promoter CpG Islands | Q24297794 | ||
Cloning and characterization of hOGG1, a human homolog of the OGG1 gene of Saccharomyces cerevisiae | Q24317398 | ||
ATM-dependent chromatin changes silence transcription in cis to DNA double-strand breaks | Q24321489 | ||
XRCC3 promotes homology-directed repair of DNA damage in mammalian cells | Q24597771 | ||
Repair of oxidative DNA damage and cancer: recent progress in DNA base excision repair | Q26822957 | ||
A bivalent chromatin structure marks key developmental genes in embryonic stem cells | Q27860977 | ||
Immunity, Inflammation, and Cancer | Q27861048 | ||
Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan | Q28005547 | ||
Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer | Q28251800 | ||
Oxidative stress, inflammation, and cancer: how are they linked? | Q29616835 | ||
ATP-dependent nucleosome remodeling | Q29618979 | ||
A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing | Q33268624 | ||
Comparing the DNA hypermethylome with gene mutations in human colorectal cancer | Q33300134 | ||
The Mi-2/NuRD complex associates with pericentromeric heterochromatin during S phase in rapidly proliferating lymphoid cells | Q33601155 | ||
A chromatin localization screen reveals poly (ADP ribose)-regulated recruitment of the repressive polycomb and NuRD complexes to sites of DNA damage | Q33715275 | ||
The chromatin-remodeling factor CHD4 coordinates signaling and repair after DNA damage | Q34110993 | ||
Cancer biology and NuRD: a multifaceted chromatin remodelling complex | Q34148512 | ||
Mismatch repair proteins recruit DNA methyltransferase 1 to sites of oxidative DNA damage. | Q34485631 | ||
Screen identifies bromodomain protein ZMYND8 in chromatin recognition of transcription-associated DNA damage that promotes homologous recombination. | Q34981653 | ||
Resistance to therapy in BRCA2 mutant cells due to loss of the nucleosome remodeling factor CHD4. | Q35173275 | ||
The TWIST/Mi2/NuRD protein complex and its essential role in cancer metastasis | Q35348193 | ||
Chromodomain helicase DNA-binding protein 4 (CHD4) regulates homologous recombination DNA repair, and its deficiency sensitizes cells to poly(ADP-ribose) polymerase (PARP) inhibitor treatment. | Q35838961 | ||
A DNA hypermethylation module for the stem/progenitor cell signature of cancer. | Q35914847 | ||
The chromatin remodeling complex NuRD establishes the poised state of rRNA genes characterized by bivalent histone modifications and altered nucleosome positions | Q35991515 | ||
Depletion of the chromatin remodeler CHD4 sensitizes AML blasts to genotoxic agents and reduces tumor formation | Q36070463 | ||
Replication fork stability confers chemoresistance in BRCA-deficient cells | Q36083474 | ||
Genome-wide nucleosome specificity and function of chromatin remodellers in ES cells | Q36912132 | ||
The NuRD complex cooperates with DNMTs to maintain silencing of key colorectal tumor suppressor genes | Q37445834 | ||
Colorectal cancer epigenetics: complex simplicity | Q37827277 | ||
H3K9 methyltransferase G9a and the related molecule GLP. | Q37865974 | ||
Interplay between the cancer genome and epigenome | Q38094260 | ||
Epigenetic Determinants of Cancer | Q38837858 | ||
Defeating EpCAM(+) liver cancer stem cells by targeting chromatin remodeling enzyme CHD4 in human hepatocellular carcinoma | Q38861692 | ||
A model for transmission of the H3K27me3 epigenetic mark | Q39927750 | ||
Targeted p16(Ink4a) epimutation causes tumorigenesis and reduces survival in mice. | Q42252961 | ||
Acetylation Enhances TET2 Function in Protecting against Abnormal DNA Methylation during Oxidative Stress. | Q50942636 | ||
Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a | Q57277034 | ||
Crosstalk between chromatin state and DNA damage response in cellular senescence and cancer | Q95407636 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 5 | |
P304 | page(s) | 653-668.e7 | |
P577 | publication date | 2017-05-01 | |
P1433 | published in | Cancer Cell | Q280018 |
P1476 | title | CHD4 Has Oncogenic Functions in Initiating and Maintaining Epigenetic Suppression of Multiple Tumor Suppressor Genes | |
P478 | volume | 31 |
Q49668158 | Aberrant DNA Methylation in Colorectal Cancer: What Should We Target? |
Q60043989 | Atypical GATA transcription factor TRPS1 represses gene expression by recruiting CHD4/NuRD(MTA2) and suppresses cell migration and invasion by repressing TP63 expression |
Q47362873 | CDYL1 fosters double-strand break-induced transcription silencing and promotes homology-directed repair |
Q55005029 | CHD4 mutations promote endometrial cancer stemness by activating TGF-beta signaling. |
Q64096094 | CHD4 regulates the DNA damage response and RAD51 expression in glioblastoma |
Q47202942 | CHD4-mediated loss of E-cadherin determines metastatic ability in triple-negative breast cancer cells |
Q91582166 | Contribution of promoter DNA sequence to heterochromatin formation velocity and memory of gene repression in mouse embryo fibroblasts |
Q90482768 | D609 protects retinal pigmented epithelium as a potential therapy for age-related macular degeneration |
Q50040373 | DNA Methylation Patterns Separate Senescence from Transformation Potential and Indicate Cancer Risk |
Q92906706 | Defining UHRF1 Domains that Support Maintenance of Human Colon Cancer DNA Methylation and Oncogenic Properties |
Q49377046 | Double duty: ZMYND8 in the DNA damage response and cancer |
Q90192573 | Dynamic Signatures of the Epigenome: Friend or Foe? |
Q47260412 | EZH2-, CHD4-, and IDH-linked epigenetic perturbation and its association with survival in glioma patients |
Q89236313 | Effects of the stimuli-dependent enrichment of 8-oxoguanine DNA glycosylase1 on chromatinized DNA |
Q92646405 | Expression of CHD5 may serve as an independent biomarker of prognosis in colorectal cancer via immunohistochemical staining |
Q89047644 | Forkhead box C1 promotes colorectal cancer metastasis through transactivating ITGA7 and FGFR4 expression |
Q42288449 | Genotranscriptomic meta-analysis of the CHD family chromatin remodelers in human cancers - initial evidence of an oncogenic role for CHD7. |
Q88683326 | HP1γ Promotes Lung Adenocarcinoma by Downregulating the Transcription-Repressive Regulators NCOR2 and ZBTB7A |
Q89581848 | Impaired lipid metabolism by age-dependent DNA methylation alterations accelerates aging |
Q92895821 | Integrative Genome-Scale DNA Methylation Analysis of a Large and Unselected Cohort Reveals 5 Distinct Subtypes of Colorectal Adenocarcinomas |
Q89094868 | LACTB, a novel epigenetic silenced tumor suppressor, inhibits colorectal cancer progression by attenuating MDM2-mediated p53 ubiquitination and degradation |
Q90099856 | MUC1-C Activates the NuRD Complex to Drive Dedifferentiation of Triple-Negative Breast Cancer Cells |
Q98192776 | NuRD subunit CHD4 regulates super-enhancer accessibility in Rhabdomyosarcoma and represents a general tumor dependency |
Q96435426 | Nucleosome-CHD4 chromatin remodeller structure maps human disease mutations |
Q64061612 | Oncogenic Roles and Inhibitors of DNMT1, DNMT3A, and DNMT3B in Acute Myeloid Leukaemia |
Q92783454 | Over-Expression of CHD4 Is an Independent Biomarker of Poor Prognosis in Patients with Rectal Cancers Receiving Concurrent Chemoradiotherapy |
Q96135596 | PHF20L1 as a H3K27me2 reader coordinates with transcriptional repressors to promote breast tumorigenesis |
Q50199064 | Prognostic significance of Cytokeratin 20-positive lymph node vascular endothelial growth factor A mRNA and chromodomain helicase DNA binding protein 4 in pN0 colorectal cancer patients. |
Q91676754 | Rational discovery of antimetastatic agents targeting the intrinsically disordered region of MBD2 |
Q45072707 | Readers of DNA methylation, the MBD family as potential therapeutic targets. |
Q57191210 | The Chromatin Reader ZMYND8 Regulates Igh Enhancers to Promote Immunoglobulin Class Switch Recombination |
Q52431146 | The chromatin-remodeling factor CHD4 is required for maintenance of childhood acute myeloid leukemia. |
Q64062256 | The chromodomain helicase CHD4 regulates ERBB2 signaling pathway and autophagy in ERBB2 breast cancer cells |
Q64214332 | The emerging role of epigenetic modifiers in repair of DNA damage associated with chronic inflammatory diseases |
Q93014579 | The genomics of oxidative DNA damage, repair, and resulting mutagenesis |
Q92502920 | The importance of including diverse populations in cancer genomic and epigenomic studies |
Q98196633 | The role of histone methylation in the development of digestive cancers: a potential direction for cancer management |
Q59446880 | The roles of base excision repair enzyme OGG1 in gene expression |
Q54957021 | Tumour-associated missense mutations in the dMi-2 ATPase alters nucleosome remodelling properties in a mutation-specific manner. |
Q57822867 | ZMYND8 acetylation mediates HIF-dependent breast cancer progression and metastasis |
Search more.